OMEGA HEALTHCARE INVESTORS INC(OHI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #692 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
OHI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for OMEGA HEALTHCARE INVESTORS INC (OHI), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores OHI at 63.2/100 on a 32-signal composite quality model, placing it at rank #692 of 2,879 stocks — the top 25% of the AI-ranked universe. OHI scores in the top quartile across free cash flow (96.2), profitability (95.9), earnings quality (83.8). Areas of concern include revenue growth (20.9) and institutional flow (31.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), OMEGA HEALTHCARE INVESTORS INC reports quarterly revenue of $323.0M, net income of $151.0M, an operating margin of 49.5%. Top institutional holders of OHI by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, STATE STREET, based on the most recent SEC filings. OHI trades on the NYSE exchange and files with the SEC under CIK 888491. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OHI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OMEGA HEALTHCARE INVESTORS INC directly from SEC EDGAR. OMEGA HEALTHCARE INVESTORS INC's 13F Pro composite quality score has ranged between 8 and 77 since 2021, currently 63.2 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$323.0M
Net Income
Q1 2026
$151.0M
Free Cash Flow
Q1 2026
$215.5M
Operating Margin
Q1 2026
49.5%
ROIC
Q1 2026
3.1%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+25.3% YoYNet Income
+237116.4% YoYOperating Income
EPS (Diluted)
+94.0% YoYTotal Assets
+10.2% YoYTotal Debt
-16.0% YoYOp. Cash Flow
+42.2% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2020 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $1.19B +25.3% | $949.7M +8.1% | $878.2M -1.6% | $892.4M | $0.00 -100.0% | $908.4M |
| Net Income | $590.2M +237116.4% | $248.8K -43.3% | $438.8K | — | — | — |
| Operating Income | — | — | — | — | $497.6M +57.9% | $315.2M |
| EPS (Diluted) | $1.94 +94.0% | $1.00 -44.4% | $1.80 +157.1% | $0.70 -50.0% | $1.40 +174.5% | $0.51 |
| Total Assets | $10.05B +10.2% | $9.12B -3.1% | $9.41B -1.0% | $9.50B +10.6% | $8.59B -2.1% | $8.77B |
| Total Debt | $4.26B -16.0% | $5.07B -4.2% | $5.29B +2.3% | $5.17B +13.8% | $4.54B -0.7% | $4.57B |
| Operating Cash Flow | $878.6M +42.2% | $617.7M -1.3% | $625.7M -11.7% | $708.3M +41.8% | $499.4M -13.6% | $577.9M |
AI Insight: OHI Financial Trends
Revenue grew 28% from Q2 2024 to Q1 2026 while total debt declined $405M, strengthening the balance sheet for this healthcare REIT.
• Revenue increased from $253M in Q2 2024 to $323M in Q1 2026, showing consistent growth momentum.
• Total debt decreased from $4,661M in Q2 2024 to $4,256M in Q4 2025, reducing leverage.
• Equity grew from $3,711M in Q2 2024 to $5,191M in Q1 2026, strengthening the balance sheet.
⚠ Net income declined from $180M in Q3 2025 to $151M in Q1 2026 despite revenue growth.
⚠ Operating cash flow remains volatile, fluctuating between $182M and $239M across recent quarters.
AI Insight: OHI Ratio Trends
Operating margins surged from 47.0% in Q2 2024 to 54.2% TTM, while ROIC more than doubled from 5.7% to 12.9%.
• Operating margin expanded from 47.0% in Q2 2024 to 54.2% TTM, peaking at 61.4% in Q3 2025.
• ROIC more than doubled from 5.7% in Q2 2024 to 12.9% TTM, showing sustained capital efficiency gains.
• Debt-to-equity ratio improved from 1.26 in Q2 2024 to 0.82 in Q4 2025, strengthening balance sheet.
• Net profit margin reached 51.1% TTM, up from 39.4% in Q1 2025, reflecting strong operational leverage.
⚠ ROIC jumped to 12.3% in Q1 2026 from 7.3% in Q4 2025, creating a gap with TTM figure.
⚠ Operating margin declined to 49.5% in Q1 2026 from Q3 2025 peak of 61.4%, suggesting potential normalization.
Get alerted when OHI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for OMEGA HEALTHCARE INVESTORS INC including:
Top Institutional Holders of OHI
BlackRock, Inc.
$1.6B37,201,363 shVANGUARD PORTFOLIO MANAGEMENT LLC
$1.2B27,123,117 shSTATE STREET CORP
$638.6M14,573,313 shVANGUARD CAPITAL MANAGEMENT LLC
$579.9M13,234,121 shGEODE CAPITAL MANAGEMENT, LLC
$391.3M8,928,107 shInvesco Ltd.
$259.5M5,923,037 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$202.3M4,616,672 shDIMENSIONAL FUND ADVISORS LP
$193.8M4,423,120 shBank of New York Mellon Corp
$188.2M4,293,812 shBANK OF AMERICA CORP /DE/
$166.3M3,794,730 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $1.6B | 37,201,363 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.2B | 27,123,117 |
| STATE STREET CORP | $638.6M | 14,573,313 |
| VANGUARD CAPITAL MANAGEMENT LLC | $579.9M | 13,234,121 |
| GEODE CAPITAL MANAGEMENT, LLC | $391.3M | 8,928,107 |
| Invesco Ltd. | $259.5M | 5,923,037 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $202.3M | 4,616,672 |
| DIMENSIONAL FUND ADVISORS LP | $193.8M | 4,423,120 |
| Bank of New York Mellon Corp | $188.2M | 4,293,812 |
| BANK OF AMERICA CORP /DE/ | $166.3M | 3,794,730 |
More Real Estate Companies
View all Real Estate →Put OHI on your watchlist
Track score changes the day OMEGA HEALTHCARE INVESTORS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OHI a good stock to buy?
13F Pro's AI-powered analysis of OMEGA HEALTHCARE INVESTORS INC (OHI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OHI are available on the OHI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own OHI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OHI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OMEGA HEALTHCARE INVESTORS INC's investment landscape.